Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009 Biodel Inc. to Present at 27th Annual JPMorgan Healthcare Conference on January 15th, 2009
DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the 27th Annual JPMorgan Healthcare Conference on Thursday, January 15, 2009 at 8:30 a.m. Pacific Time.
The JPMorgan Healthcare Conference will be held January 12-15, 2009, at the Westin St. Francis Hotel in San Francisco, California.
Interested parties may access the presentation in the investor relations section of Biodel's website at [ www.biodel.com ] which will link to a live webcast to be archived for 14 days.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.Biodel.com ].
BIOD-G
